| Name of the Instrument/Tool | Rheumatoid Arthritis Self Efficacy Scale (RASE) |
| First Description |
Hewlett S, Cockshott Z, Kirwan J, Barrett J, Stamp J, Haslock I. Development and validation of a self‐efficacy scale for use in British patients with rheumatoid arthritis (RASE). Rheumatology. 2001;40(11):1221-30. |
| Year | 2001 |
| Domains | |
| Concept of constructs | --- |
| Population/Disease | Disease specific |
| Originally developed for | Rheumatoid Arthritis (RA) |
| Other rheumatic diseases where can be applied (only if validated) |
--- |
| Additional population with no rheumatic diseases |
No |
| Language: Originally published in | English |
| Available in Language | Danish, English |
| REFERENCE IDENTIFICATION | |
| Author/s | Hewlett S, Cockshott Z, Kirwan J, Barrett J, Stamp J, Haslock I. |
| Title | Development and validation of a self-efficacy scale for use in British patients with rheumatoid arthritis (RASE) |
| Journal | Rheumatology (Oxford) |
| Year | 2001 |
| Vol | 40 |
| Num | 11 |
| Pages | 1221-1230 |
| Country | UK |
| Language | English |
| Other references of interest | |
| Link | http://www.ncbi.nlm.nih.gov/pubmed/18228530 |
| Brief Description |
Hewlett S, Cockshott Z, Almeida C, Richards P, Lowe R, Greenwood R, Kirwan J; RASE Study Group. Sensitivity to change of the Rheumatoid Arthritis Self-Efficacy scale (RASE) and predictors of change in self-efficacy. Musculoskeletal Care. 2008 Mar;6(1):49-67 |
| Link | http://www.ncbi.nlm.nih.gov/pubmed/22046509 |
| Brief Description |
Mielenz TJ, Edwards MC, Callahan LF. Item Response Theory Analysis of Two Questionnaire Measures of Arthritis-Related Self-Efficacy Beliefs from Community-Based US Samples. Arthritis. 2010;2010:416796 |
| Link | http://www.ncbi.nlm.nih.gov/pubmed/22588769 |
| Brief Description |
Brady TJ. Measures of self-efficacy: Arthritis Self-Efficacy Scale (ASES), Arthritis Self-Efficacy Scale-8 Item (ASES-8), Children's Arthritis Self-Efficacy Scale (CASE), Chronic Disease Self-Efficacy Scale (CDSES), Parent's ArthritisSelf-Efficacy Scale (PASE), and Rheumatoid Arthritis Self-Efficacy Scale (RASE). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S473-85 |
| Instrument/Tool Translations References | |
| Link | http://www.ncbi.nlm.nih.gov/pubmed/20229609 |
| Brief Description |
Primdahl J, Wagner L, Hørslev-Petersen K. Self-efficacy in rheumatoid arthritis: translation and test of validity, reliability and sensitivity of the Danish version of the Rheumatoid Arthritis Self-Efficacy Questionnaire (RASE). Musculoskeletal Care. 2010 Sep;8(3):123-35 |
| DEVELOPER CONTACT INFORMATION | |
| Correspondence to | Sarah Hewlett, PhD, MA, RN |
| Sarah.Hewlett@uwe.ac.uk | |
| Address | Academic Rheumatology, Bristol Royal Infirmary, Bristol BS2 8HW, UK |
| Website | --- |
| Available | --- |
| Links | --- |
| DESCRIPTION OF THE INSTRUMENT | |
| Type Of Measure | Questionnaire |
| Brief Description |
The RASE was developed to measure taskspecific self-efficacy for the initiation of self-management–related behavior, and was carefully worded to tap beliefs about capability to perform the behavior, rather than actual ability, performance, or outcome expectation. |
| Number of Items | 28 |
| Range | 28-140 |
| Responses options/scale |
Yes Likert scale with response options 1 (strongly disagree) to 5 (strongly agree) |
| Developed for | Research |
| PRACTICAL APPLICATION | |
| Method of administration | Self-administered |
| Recommendations to score |
Scoring is obtained by addition of responses; no computer is necessary. There are no instructions for handling missing items |
| Score Interpretation | higher scores indicate greater self-efficacy |
| Cut-off points | not available |
| Cut-off points applied to | --- |
| Smallest detectable change if described | not available |
| Smallest detectable change applied to | --- |
| Completion time by the patient | 0 minutes |
| Scoring time by the assessor | 0 minutes |
| Training to score | Not necessary |
| Strengths | Useful in clinical practice & research |
| Limitations | --- |
| OTHER COMMENTS | |
| Other Comments | --- |